4925 Results

People

  1. Giralt
    Giralt
  2. Berger
    Berger
  3. Morrow
    Morrow
  4. Horwitz
    Horwitz
  5. Ladanyi
    Ladanyi
  6. Lee
    Lee
  7. Adusumilli
    Adusumilli
  8. Hyman
    Hyman
  9. Perales
    Perales
  10. Solit
    Solit

Groups

  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)
  7. Center for Hematologic Malignancies (764)
  8. Hematologic Malignancies, Division of (714)
  9. Department of Pathology and Laboratory Medicine (653)
  10. Population Sciences Research Program (632)
  1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing
    Meeting Abstract

    Fan, P. D.; Narzisi, G.; Jayaprakash, A.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Jordan, E.; Wang, L.; Jungbluth, A. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib
    Meeting Abstract

    D'Souza, A.; Shishedo, S.; Spicer, D. V.; Welter, L.; Jiang, Y.; Hyman, D. M.; Solit, D. B.; Ma, C. X.; Bose, R.; Cutler, R. E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Genome-wide association study (GWAS) of chemotherapy-induced Raynaud's phenomenon (RP) to reveal shared pathways with cardiovascular disease (CVD)
    Meeting Abstract

    El Charif, O.; Wheeler, H. E.; Trendowski, M.; Gamazon, E. R.; Ardeshirrouhanifard, S.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Beard, C.; Fung, C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Molecular landscape of fibrolamellar carcinoma (FLC): Beyond the DNAJB1-PRKACA chimera
    Meeting Abstract

    El Dika, I. H.; Capanu, M.; Berger, M. F.; Arcila, M. E.; Benayed, R.; Harding, J. J.; Rusek, M.; Valentino, E.; O'Reilly, E. M.; Saltz, L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A situation where hepatocellular carcinoma (HCC) may be more common in women than men: Clinical and genetic patterns of non risk-factored HCC
    Meeting Abstract

    El Dika, I. H.; Harding, J. J.; Capanu, M.; Berger, M. F.; Rebibo, D.; Rusek, M.; Chou, J. F.; O'Reilly, E. M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase Ib study of cetuximab + BYL719 + IMRT in stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Riaz, N.; Baxi, S. S.; McBride, S. M.; Sherman, E. J.; Michel, L.; Haque, S.; Katabi, N.; Wong, R. J.; Xiao, H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Baseline frequency of brain metastases and outcomes with multikinase inhibitor therapy in patients with RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Filleron, T.; Bergagnini, I.; Milia, J.; Hatzoglou, V.; Velcheti, V.; Besse, B.; Mok, T.; Awad, M. M.; Wolf, J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Factors associated with participating in formal support services among family caregivers of older adults with poor-prognosis cancers
    Meeting Abstract

    Dionne-Odom, J. N.; Applebaum, A.; Ornstein, K.; Azuero, A.; Warren, P.; Taylor, R. A.; Rocque, G. B.; Kvale, E. A.; Demark-Wahnefried, W.; Pisu, M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Donskov, F.; Motzer, R. J.; Voog, E.; Hovey, E. J.; Grùˆllich, C.; Nott, L. M.; Cuff, K. E.; Gil, T.; Jensen, N. V.; Chevreau, C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Changes in CTC burden and prevalence of specific CTC subtypes in mCRPC patients (pts) receiving alpharadin (Ra-223) as single agent or in combination with other therapuetics (Tx)
    Meeting Abstract

    Dittamore, R. V.; Jendrisak, A.; Schreiber, N. A.; McLaughlin, B.; Graf, R.; Rodriguez, A.; Fleisher, M.; Lee, J.; Kelvin, J.; Wang, Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save